Insight Molecular Diagnostics Cash Flow Statement (2015-2026) | IMDX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-10.49M-13.80M-35.69M-6.88M-6.94M-7.51M-32.96M-2.93M-9.13M-4.63M-13.52M14.68M-6.80M-9.84M-11.05M17.14M-4.41M
Depreciation and Depletion (Quarter)
0.21M0.26M0.26M0.29M0.38M0.39M0.47M0.45M0.43M0.40M
Share-based Compensation (Quarter)
2.00M1.85M1.71M2.01M2.23M3.18M2.62M0.83M0.83M0.61M0.48M0.42M0.39M0.45M0.50M0.47M0.50M0.52M0.72M0.61M
Deferred Taxes (Quarter)
-1.79M0.10M
Gains from Sales and Divestitures (Quarter)
0.00M0.02M0.09M
Gains from Investment Securities (Quarter)
0.33M1.17M25.01M-4.66M3.43M1.22M17.26M-18.31M0.18M0.30M11.19M0.27M7.14M-9.59M0.88M0.02M1.29M0.00M
Asset Writedowns and Impairment (Quarter)
5.00M-0.05M1.81M-0.00M36.90M
Non-cash Items (Quarter)
19.10M0.19M0.22M0.02M0.14M0.11M0.52M8.54M0.28M
Cash from Operations (Quarter)
-8.06M-10.98M-7.07M-13.28M-11.25M-11.40M-9.65M-8.30M-6.83M-3.77M-4.42M-3.83M-5.98M-5.53M-5.35M-5.84M-6.30M-4.50M-5.54M-7.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.07M0.99M0.99M0.93M0.98M0.98M0.81M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.01M
Amortization of Deferred Charges (Quarter)
0.01M0.01M0.01M0.01M0.00M0.00M
Depreciation & Amortization (CF) (Quarter)
0.21M0.26M0.22M0.29M0.38M0.39M0.40M0.45M0.43M0.40M0.31M0.31M0.30M0.32M0.56M0.49M0.56M0.58M0.60M0.63M
Change in Working Capital
Change in Receivables (Quarter)
0.32M0.01M0.41M0.69M-0.32M0.19M0.02M-0.11M-0.18M0.17M0.02M-0.32M-0.08M0.12M1.40M1.93M-3.03M-0.25M0.87M-0.97M
Change in Inventory (Quarter)
0.23M0.18M0.05M0.23M-0.22M-0.03M-0.06M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
-1.17M-0.83M0.24M-0.02M0.26M0.18M-0.12M-2.66M-1.66M0.13M-0.56M0.85M-1.24M0.65M0.70M1.03M-3.11M1.18M3.56M-0.10M
Other Working Capital Changes (Quarter)
0.08M0.07M-0.02M-0.04M-0.01M0.80M-0.51M-0.03M-0.09M0.07M-0.06M0.06M-0.18M-0.17M0.09M-0.15M-0.06M-0.02M-0.08M
Investing Activities
Capital Expenditures (Quarter)
0.61M0.39M0.40M1.56M1.12M0.86M0.80M-0.56M0.26M0.02M0.19M0.09M0.21M0.31M0.35M1.05M1.48M0.61M
Sales of Property, Plant and Equipment (Quarter)
0.23M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-4.89M-0.39M-0.40M-1.56M-1.12M-0.86M-0.80M-1.37M0.12M0.21M0.10M-0.02M-0.19M-0.09M-0.21M-0.31M-0.35M-1.05M-1.48M-0.61M
Financing Activities
Other financing activities (Quarter)
-0.00M0.54M0.84M0.49M-0.41M1.18M
Cash from Financing Activities (Quarter)
0.55M8.21M-0.27M-0.35M36.79M-0.53M-0.10M-0.03M12.27M-0.03M-0.03M9.85M-0.26M10.84M28.56M-0.11M-0.12M-0.25M24.70M
Additional items
Exchange Rate Effect (Quarter)
-0.00M-0.02M-0.01M-0.01M
Change in Cash (Quarter)
-12.40M-3.16M-7.74M-15.21M24.45M-12.78M-10.55M-9.70M5.57M-3.58M-4.35M-3.85M3.68M-5.89M5.27M22.39M-6.74M-5.78M-7.29M16.44M
Free Cash Flow (Quarter)
-8.67M-11.38M-7.47M-14.84M-12.37M-12.26M-10.45M-8.30M-6.83M-3.21M-4.69M-3.85M-6.17M-5.62M-5.57M-6.15M-6.65M-5.55M-7.02M-8.25M
Net Cash Flow (Quarter)
-12.40M-3.16M-7.74M-15.19M24.42M-12.78M-10.55M-9.70M5.57M-3.58M-4.35M-3.85M3.68M-5.87M5.28M22.41M-6.76M-5.67M-7.28M16.45M